DarioHealth Corp. (NASDAQ: DRIO): Growing Sales By 282% With Record Q4 On Tap

Nothing advances share prices like the strong top and bottom line growth DarioHealth Corp. (DRIO) is experiencing DRIO reported a whopping 282% growth in sales for the previous 9 month period ending last September Expect a record Q4 and full 2016 results when DRIO reports next month,a strong catalyst to drive shares higher Approval for the Android version of the DarioSmart Diabetes Management Solution is expected by mid-2017, another positive catalyst for the company Near-term launch in Germany also pending Coming off a $5.1 million raise last month, DRIO has a strong balance sheet to continue rapid market penetration DRIO has a uniquebusiness model in the Mobile Health (mHealth) space that helps customers better manage their diabetes, and that model, (along with the Company’s proprietary technology), is the driving force behind the growth

Submitted March 30, 2017 at 12:58PM by focusedstocktrader http://ift.tt/2nAelEL